AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 23.1% in February

AstraZeneca PLC (OTCMKTS:AZNCF) saw a large growth in short interest in February. As of February 15th, there was short interest totalling 322,700 shares, a growth of 23.1% from the January 31st total of 262,200 shares. Based on an average trading volume of 3,200 shares, the short-interest ratio is presently 100.8 days.

AstraZeneca Trading Up 2.9 %

AstraZeneca stock opened at $157.58 on Thursday. AstraZeneca has a 52 week low of $120.64 and a 52 week high of $175.00. The stock has a 50-day simple moving average of $140.36 and a 200 day simple moving average of $145.01.

AstraZeneca Increases Dividend

The firm also recently declared a dividend, which will be paid on Monday, March 24th. Investors of record on Friday, February 21st will be issued a dividend of $2.10 per share. The ex-dividend date is Wednesday, February 19th. This is a boost from AstraZeneca’s previous dividend of $1.00. AstraZeneca’s dividend payout ratio (DPR) is presently 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.